To identify risk factors for gross hematuria (GH) in nonagenarians and assess their impact on hospital admissions and discharge outcomes, including survival and resource utilization.
Key Findings:
Almost half of nonagenarian admissions to urology were due to GH, highlighting the need for targeted interventions.
CSHA-CFS >6 was associated with worse survival outcomes, indicating frailty as a critical factor.
Antithrombotic therapy, indwelling catheters, and history of bladder cancer were significant predictors of GH, suggesting areas for clinical focus.
Interpretation:
Identifying predictors of GH in nonagenarians can enhance patient-centered care by informing targeted interventions and resource allocation in urological practice.
Limitations:
Retrospective design may introduce bias, including selection and information bias.
Data limited to a single institution may affect generalizability and applicability to broader populations.
Conclusion:
Understanding risk factors for GH in nonagenarians is crucial for improving clinical decision-making and patient outcomes, ultimately enhancing care for an aging population.
